tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
PremiumCompany AnnouncementsAlaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
5M ago
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
Premium
Company Announcements
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
5M ago
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
Premium
Company Announcements
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
6M ago
Alaunos Therapeutics Raises $850,000 in Private Offering
PremiumCompany AnnouncementsAlaunos Therapeutics Raises $850,000 in Private Offering
7M ago
Alaunos Therapeutics Closes Registered Direct Offering
Premium
Company Announcements
Alaunos Therapeutics Closes Registered Direct Offering
7M ago
Alaunos prices 610,399 shares at $3.36 in registered direct offering
Premium
The Fly
Alaunos prices 610,399 shares at $3.36 in registered direct offering
7M ago
Five new option listings and  option delistings on January 21st
PremiumThe FlyFive new option listings and option delistings on January 21st
12M ago
Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
Premium
Company Announcements
Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
1y ago
ZIOPHARM Oncology trading halted, news pending
Premium
The Fly
ZIOPHARM Oncology trading halted, news pending
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100